English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Experts call for greater focus on shisha smoking in UK public health policy
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Study finds cholera bacteria and virus in ongoing evolutionary battle in South Asia
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Study finds higher heart disease risk in long COVID patients
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Pharmaceutical companies delay European drug launches to avoid U.S. price reductions
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Ohio State Health and Discovery outlines hepatitis C testing recommendations
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Experts discuss advancements in radiotherapeutics and isotope use for cancer treatment
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Pfizer and BioNTech stop large US COVID-19 vaccine trial due to slow enrollment

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes